Manhattan Associates (MANH) announced the retirements of Joh. Huntz, Jr., and Deepak Raghavan from its Board of Directors. Huntz served on the Manhattan Board and as Chair of its Audit Committee for over 26 years, and as Chairman of the Board for the last 22 years. Dr. Raghavan co-founded Manhattan in 1990, served as its head of technology, and then its head of product strategy, as well as on its Board, through 2002. Since then, he has continued to serve on the Board, including as Chair of its Nomination and Governance Committee. Following the retirement of Mr. Huntz and Dr. Raghavan, the Board has appointed Eddie Capel as Executive Chairman of the Board. Mr. Capel joined Manhattan in 2000, served as President and CEO from 2013 to February 2025, and has been a board member since July 2012. Most recently, since his retirement as President and CEO in February, Mr. Capel has served as Executive Vice-Chairman of the Board. Manhattan’s Board also appointed current Board member Thomas Noonan as the Board’s Lead Independent Director and Danielle Sheer as a director. Noonan has served on Manhattan’s Board since 1999, and as a member of its Audit and Compensation Committees, most recently serving as the Compensation Committee Chair. Noonan is co-founder and current general partner of TechOperators. Sheer serves as Chief Trust Officer at Commvault Systems.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MANH:
- MANH Lawsuit Alert! Class Action Lawsuit Against Manhattan Associates
- Manhattan Associates’ Earnings Call Highlights Growth Amid Challenges
- Manhattan Associates price target raised to $200 from $195 at DA Davidson
- Manhattan Associates price target raised to $190 from $180 at Truist
- Manhattan Associates price target lowered to $195 from $270 at Raymond James